View ValuationUzin Utz 将来の成長Future 基準チェック /26Uzin Utz利益と収益がそれぞれ年間11.2%と7.9%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に10.6% 11.2%なると予測されています。主要情報11.2%収益成長率11.15%EPS成長率Chemicals 収益成長31.2%収益成長率7.9%将来の株主資本利益率10.60%アナリストカバレッジLow最終更新日20 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBuy Or Sell Opportunity • May 22Now 22% undervaluedThe stock has been flat over the last 90 days, currently trading at €62.60. The fair value is estimated to be €80.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 8.7%. For the next 3 years, revenue is forecast to grow by 7.9% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.Upcoming Dividend • May 07Upcoming dividend of €1.90 per shareEligible shareholders must have bought the stock before 14 May 2026. Payment date: 19 May 2026. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.7%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (3.9%).Reported Earnings • Apr 06Full year 2025 earnings released: EPS: €5.24 (vs €5.84 in FY 2024)Full year 2025 results: EPS: €5.24 (down from €5.84 in FY 2024). Revenue: €512.1m (up 7.4% from FY 2024). Net income: €26.4m (down 10% from FY 2024). Profit margin: 5.2% (down from 6.2% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 7.3% decline forecast for the Chemicals industry in the United Kingdom.Declared Dividend • Apr 03Dividend of €1.90 announcedDividend of €1.90 is the same as last year. Ex-date: 14th May 2026 Payment date: 19th May 2026 Dividend yield will be 2.7%, which is lower than the industry average of 3.0%. Sustainability & Growth The dividend has increased by an average of 6.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 7.4% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Apr 01+ 1 more updateUzin Utz SE, Annual General Meeting, May 13, 2026Uzin Utz SE, Annual General Meeting, May 13, 2026, at 10:30 W. Europe Standard Time.New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 0.8% per year for the foreseeable future. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).New Risk • Feb 20New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 0.4% per year for the foreseeable future.お知らせ • Jan 08+ 3 more updatesUzin Utz SE to Report Q3, 2026 Results on Nov 13, 2026Uzin Utz SE announced that they will report Q3, 2026 results on Nov 13, 2026Reported Earnings • Aug 20First half 2025 earnings released: EPS: €2.77 (vs €2.45 in 1H 2024)First half 2025 results: EPS: €2.77 (up from €2.45 in 1H 2024). Revenue: €251.8m (up 3.9% from 1H 2024). Net income: €13.9m (up 13% from 1H 2024). Profit margin: 5.5% (up from 5.1% in 1H 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 17% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 5% per year.Buy Or Sell Opportunity • Jul 31Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to €69.00. The fair value is estimated to be €55.27, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 5.1%. For the next 3 years, revenue is forecast to grow by 4.4% per annum. Earnings are also forecast to grow by 2.6% per annum over the same time period.Declared Dividend • May 02Dividend increased to €1.90Dividend of €1.90 is 19% higher than last year. Ex-date: 14th May 2025 Payment date: 16th May 2025 Dividend yield will be 3.0%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (33% earnings payout ratio) and cash flows (24% cash payout ratio). The dividend has increased by an average of 7.8% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 5.0% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Declared Dividend • Apr 05Dividend increased to €1.90Dividend of €1.90 is 19% higher than last year. Ex-date: 14th May 2025 Payment date: 16th May 2025 Dividend yield will be 3.1%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (21% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 4.9% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Apr 04Uzin Utz SE announces Annual dividend, payable on May 16, 2025Uzin Utz SE announced Annual dividend of EUR 1.9000 per share payable on May 16, 2025, ex-date on May 14, 2025 and record date on May 15, 2025.お知らせ • Apr 03Uzin Utz SE, Annual General Meeting, May 13, 2025Uzin Utz SE, Annual General Meeting, May 13, 2025, at 10:30 W. Europe Standard Time.New Risk • Apr 03New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 3.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 3.5% per year for the foreseeable future.Reported Earnings • Apr 03Full year 2024 earnings released: EPS: €5.84 (vs €4.48 in FY 2023)Full year 2024 results: EPS: €5.84 (up from €4.48 in FY 2023). Revenue: €483.7m (flat on FY 2023). Net income: €29.4m (up 30% from FY 2023). Profit margin: 6.1% (up from 4.7% in FY 2023). Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 7% per year.お知らせ • Apr 01+ 3 more updatesUzin Utz SE to Report Q1, 2025 Results on May 13, 2025Uzin Utz SE announced that they will report Q1, 2025 results on May 13, 2025New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).Reported Earnings • Aug 17First half 2024 earnings released: EPS: €2.45 (vs €2.19 in 1H 2023)First half 2024 results: EPS: €2.45 (up from €2.19 in 1H 2023). Revenue: €242.3m (down 1.0% from 1H 2023). Net income: €12.4m (up 12% from 1H 2023). Profit margin: 5.1% (up from 4.5% in 1H 2023). Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Mar 29Uzin Utz SE, Annual General Meeting, May 22, 2024Uzin Utz SE, Annual General Meeting, May 22, 2024. Location: Donauhalle, Ulm Ulm Germanyお知らせ • Jan 13+ 3 more updatesUzin Utz SE to Report Q3, 2023 Results on Nov 15, 2023Uzin Utz SE announced that they will report Q3, 2023 results on Nov 15, 2023Valuation Update With 7 Day Price Move • Sep 20Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €43.60, the stock trades at a trailing P/E ratio of 8.3x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 10% over the past three years.業績と収益の成長予測LSE:0NLT - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028626352154212/31/2027577282355212/31/2026536232536212/31/2025506261334N/A9/30/2025496292140N/A6/30/2025486312846N/A3/31/2025482303450N/A12/31/2024477294053N/A9/30/2024477274051N/A6/30/2024478244148N/A3/31/2024479233748N/A12/31/2023480233449N/A9/30/2023483232243N/A6/30/202348623937N/A3/31/202348724-1022N/A12/31/202248825-297N/A9/30/202247726-339N/A6/30/202246526-3710N/A3/31/202245330-1526N/A12/31/202144133842N/A9/30/2021430362750N/A6/30/2021419394659N/A3/31/2021402344657N/A12/31/2020384294656N/A9/30/2020379254554N/A6/30/2020374214553N/A3/31/2020374213646N/A12/31/2019373212840N/A9/30/201936818N/A30N/A6/30/201936315N/A20N/A3/31/201935715N/AN/AN/A12/31/201834714N/A15N/A9/30/201833315N/A14N/A6/30/201832017N/A12N/A3/31/201830716N/AN/AN/A12/31/201729717N/A22N/A9/30/201729117N/A23N/A6/30/201728618N/A25N/A3/31/201727917N/AN/AN/A12/31/201627417N/A27N/A9/30/201627017N/A25N/A6/30/201626617N/A24N/A3/31/201626015N/A22N/A12/31/201525414N/A20N/A9/30/201524813N/A20N/A6/30/201524112N/A20N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 0NLTの予測収益成長率 (年間11.2% ) は 貯蓄率 ( 3.4% ) を上回っています。収益対市場: 0NLTの収益 ( 11.2% ) UK市場 ( 11.5% ) よりも低い成長が予測されています。高成長収益: 0NLTの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 0NLTの収益 ( 7.9% ) UK市場 ( 4.6% ) よりも速いペースで成長すると予測されています。高い収益成長: 0NLTの収益 ( 7.9% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 0NLTの 自己資本利益率 は、3年後には低くなると予測されています ( 10.6 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/19 15:04終値2026/06/16 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Uzin Utz SE 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Patrick SpeckMontega AGPhilipp KaiserWarburg Research GmbH
Buy Or Sell Opportunity • May 22Now 22% undervaluedThe stock has been flat over the last 90 days, currently trading at €62.60. The fair value is estimated to be €80.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 8.7%. For the next 3 years, revenue is forecast to grow by 7.9% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
Upcoming Dividend • May 07Upcoming dividend of €1.90 per shareEligible shareholders must have bought the stock before 14 May 2026. Payment date: 19 May 2026. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.7%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (3.9%).
Reported Earnings • Apr 06Full year 2025 earnings released: EPS: €5.24 (vs €5.84 in FY 2024)Full year 2025 results: EPS: €5.24 (down from €5.84 in FY 2024). Revenue: €512.1m (up 7.4% from FY 2024). Net income: €26.4m (down 10% from FY 2024). Profit margin: 5.2% (down from 6.2% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 7.3% decline forecast for the Chemicals industry in the United Kingdom.
Declared Dividend • Apr 03Dividend of €1.90 announcedDividend of €1.90 is the same as last year. Ex-date: 14th May 2026 Payment date: 19th May 2026 Dividend yield will be 2.7%, which is lower than the industry average of 3.0%. Sustainability & Growth The dividend has increased by an average of 6.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 7.4% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Apr 01+ 1 more updateUzin Utz SE, Annual General Meeting, May 13, 2026Uzin Utz SE, Annual General Meeting, May 13, 2026, at 10:30 W. Europe Standard Time.
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 0.8% per year for the foreseeable future. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
New Risk • Feb 20New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 0.4% per year for the foreseeable future.
お知らせ • Jan 08+ 3 more updatesUzin Utz SE to Report Q3, 2026 Results on Nov 13, 2026Uzin Utz SE announced that they will report Q3, 2026 results on Nov 13, 2026
Reported Earnings • Aug 20First half 2025 earnings released: EPS: €2.77 (vs €2.45 in 1H 2024)First half 2025 results: EPS: €2.77 (up from €2.45 in 1H 2024). Revenue: €251.8m (up 3.9% from 1H 2024). Net income: €13.9m (up 13% from 1H 2024). Profit margin: 5.5% (up from 5.1% in 1H 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 17% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 5% per year.
Buy Or Sell Opportunity • Jul 31Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to €69.00. The fair value is estimated to be €55.27, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 5.1%. For the next 3 years, revenue is forecast to grow by 4.4% per annum. Earnings are also forecast to grow by 2.6% per annum over the same time period.
Declared Dividend • May 02Dividend increased to €1.90Dividend of €1.90 is 19% higher than last year. Ex-date: 14th May 2025 Payment date: 16th May 2025 Dividend yield will be 3.0%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (33% earnings payout ratio) and cash flows (24% cash payout ratio). The dividend has increased by an average of 7.8% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 5.0% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Declared Dividend • Apr 05Dividend increased to €1.90Dividend of €1.90 is 19% higher than last year. Ex-date: 14th May 2025 Payment date: 16th May 2025 Dividend yield will be 3.1%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (21% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 4.9% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Apr 04Uzin Utz SE announces Annual dividend, payable on May 16, 2025Uzin Utz SE announced Annual dividend of EUR 1.9000 per share payable on May 16, 2025, ex-date on May 14, 2025 and record date on May 15, 2025.
お知らせ • Apr 03Uzin Utz SE, Annual General Meeting, May 13, 2025Uzin Utz SE, Annual General Meeting, May 13, 2025, at 10:30 W. Europe Standard Time.
New Risk • Apr 03New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 3.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 3.5% per year for the foreseeable future.
Reported Earnings • Apr 03Full year 2024 earnings released: EPS: €5.84 (vs €4.48 in FY 2023)Full year 2024 results: EPS: €5.84 (up from €4.48 in FY 2023). Revenue: €483.7m (flat on FY 2023). Net income: €29.4m (up 30% from FY 2023). Profit margin: 6.1% (up from 4.7% in FY 2023). Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 7% per year.
お知らせ • Apr 01+ 3 more updatesUzin Utz SE to Report Q1, 2025 Results on May 13, 2025Uzin Utz SE announced that they will report Q1, 2025 results on May 13, 2025
New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
Reported Earnings • Aug 17First half 2024 earnings released: EPS: €2.45 (vs €2.19 in 1H 2023)First half 2024 results: EPS: €2.45 (up from €2.19 in 1H 2023). Revenue: €242.3m (down 1.0% from 1H 2023). Net income: €12.4m (up 12% from 1H 2023). Profit margin: 5.1% (up from 4.5% in 1H 2023). Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Mar 29Uzin Utz SE, Annual General Meeting, May 22, 2024Uzin Utz SE, Annual General Meeting, May 22, 2024. Location: Donauhalle, Ulm Ulm Germany
お知らせ • Jan 13+ 3 more updatesUzin Utz SE to Report Q3, 2023 Results on Nov 15, 2023Uzin Utz SE announced that they will report Q3, 2023 results on Nov 15, 2023
Valuation Update With 7 Day Price Move • Sep 20Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €43.60, the stock trades at a trailing P/E ratio of 8.3x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 10% over the past three years.